BCM joins the Parkinson's Progression Markers Initiative
HOUSTON — June 3, 2010 — Baylor College of Medicine has been selected as one of 18 official study sites for the Parkinson's Progression Markers Initiative (PPMI), a landmark observational clinical study sponsored by The Michael J. Fox Foundation, which will use a combination of advanced imaging, biologics sampling and behavioral assessments to identify biomarkers of Parkinson's disease progression. Enrollment of 20 PD patients and 10 controls at BCM is expected to begin this summer and will continue for approximately two years.
"PPMI holds potential not only to accelerate the development of breakthrough Parkinson's treatments for the future, but also to improve diagnosis and treatment of today's generation of PD patients," said Joseph Jankovic, M.D., professor of neurology, distinguished chair in movement disorders, Baylor College of Medicine, and principal investigator of PPMI at BCM. "Baylor College of Medicine has been at the forefront of Parkinson's disease research for years in Texas. It is deeply meaningful to have been selected as a PPMI site and to have our commitment to speeding Parkinson's solutions recognized."
To learn more, visit www.ppmi-info.org.